23234-35-7

Basic information

• Product Name: BOC-LYS(Z)-GLY-OME
• Synonyms: BOC-LYS(Z)-GLY-OME
• CAS NO: 23234-35-7
• Molecular Formula: C₂₂H₃₃N₃O₇
• Molecular Weight: 451.51
• Mol File: 23234-35-7.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: BOC-LYS(Z)-GLY-OME(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-LYS(Z)-GLY-OME(23234-35-7)
• EPA Substance Registry System: BOC-LYS(Z)-GLY-OME(23234-35-7)

Safety Data

• Hazardous Substances Data: 23234-35-7(Hazardous Substances Data)

Upstream product

• 34404-36-9 Boc-Lys(Z)-OSu 
• 5680-79-5 glycine ethyl ester hydrochloride 
• 2389-45-9 Boc-Lys(Z)-OH 
• 1280225-81-1 C₂₉H₄₁N₃O₈ 
• 616-34-2 methoxycarbonylmethylamine 
• 2389-46-0 N-α-tert-butyloxycarbonyl-N-ε-benzyloxycarbonyl-lysine p-nitrophenyl ester 

Downstream Products

• 1295578-87-8 Boc-Lys(4-[1-{2,2,6,6-tetramethylpiperidin-1-yloxy}ethyl]benzoyl)-Gly-OMe 
• 1295579-09-7 Boc-Lys(4-[1-{2,2,6,6-tetramethylpiperidin-1-yloxy}ethyl]benzoyl)-Gly-OH 
• 1295578-90-3 HCl*Lys(4-[1-{2,2,6,6-tetramethylpiperidin-1-yloxy}ethyl]benzoyl)-Gly-OMe 
• 1295578-95-8 Boc-Lys(4-[1-{1-tert-butyl-3,3,5,5-tetraethylpiperazin-2-on-1-yloxy}ethyl]benzoyl)-Gly-OMe 
• 1295579-05-3 Boc-Lys(4-[1-{1-tert-butyl-3,3,5,5-tetraethylpiperazin-2-on-1-yloxy}ethyl]benzoyl)-Gly-OH 
• 1295579-06-4 HCl*Lys(4-[1-{1-tert-butyl-3,3,5,5-tetraethylpiperazin-2-on-1-yloxy}ethyl]benzoyl)-Gly-OMe 
• 1295579-07-5 Boc-bis[Lys(4-[1-{1-tert-butyl-3,3,5,5-tetraethylpiperazin-2-on-1-yloxy}ethyl]benzoyl)-Gly]-OH 
• 1295579-08-6 HCl*bis[Lys(4-[1-{1-tert-butyl-3,3,5,5-tetraethylpiperazin-2-on-1-yloxy}ethyl]benzoyl)-Gly]-OMe 
• 57022-32-9 (S)-3-(4-aminobutyl)piperazine-2,5-dione 
• 63276-43-7 N-6-Benzyloxycarbonyl-L-lysyl>-glycin-methylester 
• 112120-75-9 Boc-(Lys(Z)-Gly)3-ONSu 
• 112120-73-7 Boc-(Lys(Z)-Gly)3-OMe 
• 112120-74-8 Boc-(Lys(Z)-Gly)3-OH 
• 112097-72-0 cyclo(-Lys(Z)-Gly-)3 

Relevant articles and documents

ADVANCED GLYCATION END-PRODUCT BREAKING BIOCATALYSTS

In various aspects and embodiments the invention provides compositions and methods for removing glucosepane from one or more proteins in a subject. In certain embodiments, the method comprises administering to the subject an effective amount of a polypept

Aggregation behaviour of peptide-polymer conjugates containing linear peptide backbones and multiple polymer side chains prepared by nitroxide-mediated radical polymerization

A series of peptides with an alternating sequence of alkoxyamine conjugated lysine and glycine residues were synthesized by classical solution phase peptide coupling. The resulting peptides containing up to eight alkoxyamine moieties were used as initiato

MODIFIED MACROMOLECULE

The present invention relates to a macromolecule having a controlled terminal group stoichiometry, the macromolecule including a surface layer, at least one subsurface layer and at least two terminal groups including: a first terminal group which is a res